Company Filing History:
1 out of 832,761 Years Active: 2001
Title: Inventor Profile: Constantinos D Deltas from Nicosia, Cyprus
Introduction
Constantinos D Deltas is an innovative inventor based in Nicosia, Cyprus. He has made significant contributions to the field of genetics through his research and development of advanced methodologies for detecting alterations in gene sequences related to collagen. His efforts have the potential to impact the diagnosis and treatment of various pathological conditions.
Latest Patents
Constantinos D Deltas holds a patent for "Compositions and methods for detecting altered COL1A1 gene sequences." This invention encompasses compositions and methodologies useful for determining whether a subject possesses an alteration in genes encoding protein chains of Type I or Type IX collagen. The patent describes several novel intronic sequences of five human genes (COL1A1, COL1A2, COL9A1, COL9A2, and COL9A3) and provides methods for identifying pathological conditions associated with changes in these genes. The conditions include osteoporosis, osteoarthritis, chondrodysplasia, and other disorders related to collagen deficiencies, making his work vital for diagnostic and prognostic applications in medicine.
Career Highlights
Constantinos has dedicated his career to bridging the gap between genetic research and clinical application. His groundbreaking patent showcases his expertise and commitment to advancing medical diagnostics. With one patent to his name, he continues to explore innovative solutions to improve patient outcomes in the field of genetic disorders.
Collaborations
Throughout his professional journey, Constantinos D Deltas has collaborated with notable colleagues, including Darwin J Prockop and Loretta D Spotila. These collaborations reflect his ability to work effectively within a team of esteemed researchers, allowing for the cross-pollination of ideas and knowledge, ultimately enhancing the scope and impact of their work in genetics.
Conclusion
Constantinos D Deltas exemplifies the spirit of innovation and dedication to improving health outcomes through his inventive work. His contributions to the detection of altered collagen genes are paving the way for advances in understanding various diseases and conditions related to collagen deficiencies. As he continues his research, the implications of his work will likely extend further, providing valuable insight into genetic disorders and the future of personalized medicine.